Nehmen Sie Kontakt auf.

Zur Kontaktliste

Haben Sie Fragen zu Services oder zum Literaturangebot von ZB MED? Benötigen Sie Tipps zur Recherche in LIVIVO?

Kontakt

info@zbmed.de
Telefonnummer: +49 (0)221 478-5685

Köln

Medizin und Gesundheitswesen

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Gleueler Straße 60
50931 Köln

Bonn

Ernährungs-, Umwelt- und Agrarwissenschaften

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Friedrich-Hirzebruch-Allee 4
53115 Bonn

InfoCenter

INFORMATION.

WISSEN.
LEBEN.

Infrastruktur- und Forschungszentrum für lebenswissenschaftliche Daten und Informationen.

Thema Lebenswissenschaften?

Wir haben die Werkzeuge für Ihre passgenauen Recherchen.

Kongressdetails

29.11.2016 - 30.11.2016

6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine

Veranstaltungsort
München
Kontakt und Ansprechparter

BioM Biotech Cluster Development GmbH

Am Klopferspitz 19a

82152 Martinsried

info@bio-m.org

Land
Deutschland
Kurzinfo

We would like to invite you to the 6th Munich Biomarker Conference to witness how personalized medicine improves health outcomes already today. Recent advances in immunotherapy and combination therapies will be presented. As every year, the meeting highlights latest examples of biomarker discovery, validation and clinical use as well as strategies for biomarker-driven drug development. It will showcase exciting technology developments pushing the boundaries of what is feasible.


Munich is one of Europe’s leading biotech locations with a strategic focus on personalized medicine. BioM, the networking organization for biotechnology in Munich and Bavaria, is organizing the international conference in its sixth year. With the aim to accelerate biomedical innovation, we bring together international experts from biotech and pharma industry with academic scientists and physicians.


We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.